Stockreport

Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering

Titan Pharmaceuticals, Inc.  (TTNP) 
NASDAQ:AMEX Investor Relations: ir.titanpharm.com